MedTrace Logo

Angiotensin-Converting Enzyme Polymorphism and Acute Renal Failure (ECAREA)

NCT00316576 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2008-01-17

No results posted yet for this study

Summary

Associations between angiotensin-converting enzyme gene polymorphism and occurrence and outcome of ARDS, and with respiratory complications post cardiopulmonary bypass have already been demonstrated. Based on physiological effects of angiotensin II, we hypothesized that the I allele of the angiotensin-converting enzyme Insertion/Deletion polymorphism may be associated with a higher risk of acute renal failure in critically ill patients.

Conditions

  • Kidney Failure, Acute
  • Critical Illness

Interventions

PROCEDURE

Blood sampling for PCR

Sponsors & Collaborators

  • University Hospital, Caen

    lead OTHER

Principal Investigators

  • Damien du Cheyron, MD · University Hospital, Caen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-05-31
Completion
2006-11-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00316576 on ClinicalTrials.gov